Di Modugno, F; Spada, S; Palermo, B; Visca, P; Iapicca, P; Di Carlo, A; et al.(2018). hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis. Oncogene, 37(42), 5605-5617. doi: 10.1038/s41388-018-0364-3. Lawrence Berkeley National Laboratory: Retrieved from: http://www.escholarship.org/uc/item/9vr1p6q1 Oncogene Di Modugno, F, Spada, S, Palermo, B, Visca, P, Iapicca, P, Di Carlo, A, Antoniani, B, Sperduti, I, Di Benedetto, A, Terrenato, I, Mottolese, M, Gandolfi, F, Facciolo, F, Chen, E I, Schwartz, M A, Santoni, A, Bissell, M J & Nisticò, P 2018, ' hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis ', Oncogene, vol. 37, no. 42, pp. 5605-5617 . https://doi.org/10.1038/s41388-018-0364-3 Oncogene, vol 37, iss 42